50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

CareTrust REIT stock downgraded amid PACS allegations

EditorAhmed Abdulazez Abdulkadir
Published 12/09/2024, 06:28 PM
CTRE
-

On Monday, BMO Capital Markets adjusted its stance on CareTrust REIT (NYSE:CTRE), moving from an Outperform rating to Market Perform. This shift comes with a new price target set at $32.00, down from the previous target. The change in rating reflects a cautious approach following allegations surrounding one of CareTrust's significant tenants, PACS.

CareTrust REIT has seen a commendable year-to-date performance, with a 31% increase compared to the 11% gain of the RMZ index. The real estate investment trust is expected to continue this trajectory into 2025, with forecasts suggesting a 17% year-over-year growth in funds from operations (FFO), largely due to beneficial acquisitions.

Despite the optimistic growth outlook, the recent allegations involving PACS have prompted a reassessment. PACS contributes approximately 20% of CareTrust's pro-forma rents and has been a considerable factor in the company's external growth. The analyst expressed concerns over the potential impact on PACS's rent coverage, especially for new acquisitions, if there are changes to billing policies that diverge from initial underwriting expectations.

The industry in which CareTrust operates, specifically skilled nursing facilities (SNF), typically works with modest margins. These narrow margins could be further pressured if PACS's billing practices are altered in response to the allegations.

The downgrade to Market Perform indicates a neutral view on the stock's potential, suggesting that the stock may perform in line with the broader market or sector in the near term. The lowered price target to $32.00 is a direct response to the perceived risks associated with PACS and its influence on CareTrust's revenue stream.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.